Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Roundhill Magnificent Seven ETF (MAGS) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance

Roundhill Magnificent Seven ETFTrade
Roivant Sciences Ltd. Common SharesTrade

Price performance (Past 24H)

Key statistics

Roundhill Magnificent Seven ETF vs Roivant Sciences Ltd. Common Shares — how do they compare? Roundhill Magnificent Seven ETF trades at $73.96 (market cap $5.84B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 4.3× Roundhill Magnificent Seven ETF's market cap, and Roundhill Magnificent Seven ETF is trading nearer its 52-week high, Roivant Sciences Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roundhill Magnificent Seven ETF for 36 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.

MAGSROIV
Market Cap
$5.84B$25.09B
Volume
1,765,0915,738,571
Sector
Sector/ThematicHealth
52-Week High
$73.90$41.81
52-Week Low
$55.39$16.04
Typical Hold Time
36 Days0 Days
Enterprise Value
—$21.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Roundhill Magnificent Seven ETF

MAGS (Roundhill Magnificent Seven ETF) trades at $73.69, down 0.28% on the day, with a bullish technical signal from moving averages but neutral oscillators. The ETF provides equal-weighted exposure to seven mega-cap tech leaders and has delivered 181% returns since launch, though it trails the S&P 500 in 2026 with just 2% YTD gains. Recent news highlights AI-driven momentum but also concerns about the 'Magnificent Seven' theme fracturing as capital spending pressures dividends and buybacks.

The outlook remains cautiously optimistic given AI supercycle potential, but investors face concentration risk in tech and underperformance versus broader markets. Key risks include aggressive AI spending impacting cash flows and shifting investor preference toward semiconductors. Analyst sentiment is mixed, balancing long-term growth prospects against near-term valuation concerns and market rotation trends.

Roivant Sciences Ltd. Common Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MAGS
100% Buy0% Sell
Avg holding period · 36 Days
ROIV
100% Buy0% Sell
Avg holding period · 0 Days

About Roundhill Magnificent Seven ETF

MAGS is an ETF that provides concentrated exposure to the seven technology-focused mega-cap companies often referred to as the 'Magnificent Seven' (Alphabet, Amazon, Apple, Meta, Microsoft, NVIDIA, and Tesla). The fund is designed to capture the performance of these market-leading stocks, which have been the primary drivers of market returns. It offers a simple way for investors to invest solely in this select group of high-growth technology companies.

Read more on MAGS →

About Roivant Sciences Ltd. Common Shares

Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.

Read more on ROIV →